2022年美国生物材料学会年会(SFB 2022)

The Society For Biomaterials is excited to host the 2022 Annual Meeting at the Baltimore Marriott Waterfront April 27-30, 2022. In keeping with the history of our host city, the theme for the SFB 2022 Annual Meeting is The Perilous Fight to Translate Innovative Research to Commercial Viability. This year's program is focused on ideas that involve breakthroughs in biomaterials science, translation of basic research to clinical application, next-generation medical devices, and content that explores standards development, regulatory issues, and commercial realities. 

摘要征集：

The deadline to submit your abstract for a $50 submission fee is November 10, 2021 at 11:59 PM EST.

点此提交摘要>>>Submit Abstract>>>

Regardless of abstract submission date, each person who submits an abstract will be provided a discount code for $25 off of registration.

All authors must submit their abstract electronically. This is the ONLY option for abstract submission. Emailed abstract submissions will not be accepted.*

You may submit as many abstracts as you wish, however, only one $25 discount code may be applied to your registration.

Abstract Format

Abstract Requirements:

Must fit on ONE 8.5" x 11" page in a two-column format (3.25" columns, .75" margins all around, .5" between columns) inclusive of tables, graphs, or pictures
Text must be in Times New Roman font and 10-point type size
Must be uploaded as a PDF document
File size is limited to 50 megabytes
Do not upload a document with tracked changes

Title

The title should be brief, clearly indicating the nature of the presentation. When entering your title online, use mixed case (do not use all caps) and do not put a period at the end of the title.

Example: This is a Properly Formatted Abstract Title

Authors

List the authors according to the instructions given online. Author information should also be included in the abstract as formatted in the template. If authors’ names appear on more than one abstract, the names must be entered identically on each abstract to ensure proper, non-repetitive indexing in publication. Otherwise, the author’s name will appear multiple times as SFB cannot assume that the multiple listings refer to the same author. Please consult with your co-authors on how they would like their names to appear prior to the submission of the abstract.

Abstract Disclosure Statement

In order for your colleagues to properly evaluate the information, analysis, and opinions presented in your abstract, it is important that they be informed of potential conflicts of interest pertinent to the research submitted. Therefore, SFB requires that all authors provide any relevant information concerning personal or professional circumstances and relationships that might reasonably be expected to affect the author’s view on the subject. Examples include but are not limited to:

• Stock options or bond holdings in a for-profit corporation or self-directed pension plan
• Research grants
• Employment (full-time or part-time)
• Ownership or partnership
• Consulting fees or other remuneration (payment)
• Non-remunerative positions of influence such as officer, board member, trustee, or public spokesperson
• Receipt of royalties
• Speakers bureau

Disclosure information is collected on the online abstract form. Appropriate disclosure will be stated in the scientific program and the abstract volume. If you do not have anything to disclose, you must indicate this on the online abstract submission form. The disclosure information you provide will not influence the review of your abstract. Abstracts will not be reviewed without proper completion of the conflict of interest/disclosure section on the abstract submission form. Disclosure information for all authors is required upon abstract submission.

Keywords

Keywords will be used for indexing purposes. Choose up to four keywords from the list on the online abstract submission site. At least one keyword must be selected.

Content (***SEE SPECIAL NOTE FOR BIOMATERIALS TECHNOLOGY IN INDUSTRY SESSIONS***)

Content should be organized as follows:

• Statement of purpose
• Methods, materials, and analytical procedures used
• Summary of the results in sufficient detail to support conclusion
• Conclusions reached (do not state "results will be discussed")
• References to published literature

NOTE: Common reasons for abstract rejection are:

• Poorly supported research hypothesis/objective/rationale
• Experimental plan vague and/or not well documented/described
• Insufficient data collected
• Poor analysis of the data
• Conclusions not supported by the results
• Poor grammar/figures/tables

BIOMATERIALS TECHNOLOGY IN INDUSTRY

Abstracts submitted to categories within the BIOMATERIALS TECHNOLOGY IN INDUSTRY track (annotated with a *BTI* on the abstract category submission list) will be subject to loosened requirements. In recognition that speakers from industry need to protect their intellectual property, it is understood that some technical details cannot be disclosed. “Biomaterials Technology in Industry” abstracts should:

• Comply with the financial interest disclosures required of all authors;
• Follow the standard abstract submission template, with allowable relaxation of the typically rigorous "methods" section, as appropriate to ensure that proprietary information is not compromised;
• Summarize the information the author intends to convey during the session;
• May be purposely vague in areas that concern proprietary information;
• Not be commercially driven, and should not promote specific products, or make product claims.

NOTE: These sessions will be specifically delineated as distinct from the Scientific Program of the Annual Meeting with the loosened requirements articulated ubiquitously.

Tables and Graphs

Tables and graphs should be embedded in the submitted Microsoft Word or Adobe Acrobat document and must be of sufficient resolution to be reproduced clearly, typically at 300 dpi.

Acknowledgment of Receipt of Abstracts

Once your abstract has been completed, you will receive an e-mail acknowledgment to yourself and/or your co-authors from the online submission system. If you do not receive this email, this means your abstract is incomplete - Please log back in and hit “submit”.

Online Revisions

You may revise your abstract until 11:59 p.m. Eastern Standard Time on November 10, 2021, by returning to the site and logging in again.

Abstract Withdrawals

If the abstract must be withdrawn, the SFB office must be notified in writing via e-mail at [email protected].

Publication

Accepted abstracts will be published in the Transactions of the Society For Biomaterials, a referenced, copyrighted publication of the Society For Biomaterials. Under SFB copyright, authors are granted free use of SFB abstract content in other publications and abstract submissions, provided that such content is not substantially equivalent. Previously published materials may only be submitted with the permission of the copyright holder and must be properly referenced. The submitting author is responsible for securing any required copyright permissions.

Submit only ONE abstract for each presentation; DO NOT submit multiple copies of the same abstract and DO NOT submit in masked format.

Registration Requirements

Accepted authors are expected to pay their own travel expenses and conference registration fee(s).

SFB2022 注册费

You do not have to pre-register for the bash. Each registrant can attend at no charge. There is an option to purchase a guest ticket.

REFUNDS
To cancel your registration and receive a refund, a written request must be received by April 8, 2022. Cancellations can be made by contacting the Society For Biomaterials Headquarters at [email protected]. Cancellation requests received by this date will receive a refund (less a $75 processing fee). Requests will be processed upon notification. All requests received after April 8, 2022, will forfeit 100 percent of monies paid.

会议对象: 医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。